Archive for the ‘biotech/medical’ category: Page 2571
Jul 29, 2016
How the most connected hospitals will use chatbots
Posted by Karen Hurst in categories: biotech/medical, food, health, life extension, mobile phones, robotics/AI
Sure, chatbots are useful for service industries like hospitality and food delivery, but in health care? Some groups are testing the use of chatbots to retrieve medical information from within a messaging app. At first glance, that seems a bit impersonal, but a closer look reveals a wide range of use cases where bots could make your next visit to the hospital, doctor’s office, or pharmacy faster and more effective.
Let’s run this back a bit. If you’re not familiar with bots, here’s a brief explanation. Bots are software applications that run automated tasks or scripts that serve as shortcuts for completing a certain job, but they do it faster (a lot faster) and with verve. And in health care, we spend a lot of time spent generating and retrieving information.
By putting a trained army of bots inside an application — smartphone, desktop, whatever-top — health care workers can rapidly improve throughput by simply cutting out a bunch of steps. That’s something most care providers today would welcome, especially with millions of new people entering the system as a result of the Affordable Care Act and the aging of baby boomers. With the crush of increased data entry and new regulations, costs and rote work are skyrocketing.
Continue reading “How the most connected hospitals will use chatbots” »
Jul 29, 2016
Algoma professor develops way to send emails — using only your mind
Posted by Karen Hurst in categories: biotech/medical, neuroscience
Back in 1992; me and another peer who worked with me on ORNL’s ELIMS use to wish we had this technology then. And, now it looks like we’re getting closer to this capability.
An Algoma University professor has made strides in developing technology that lets ALS patients compose emails without typing.
Continue reading “Algoma professor develops way to send emails — using only your mind” »
Jul 29, 2016
Scientists find cancer in million-year-old fossil
Posted by Karen Hurst in category: biotech/medical
Cancer ever since a million years ago.
Maybe cancer isn’t so modern after all. A new discovery suggests the disease is more than a million years old.
Jul 29, 2016
New rare form of hereditary colon cancer identified
Posted by Karen Hurst in categories: biotech/medical, genetics
Researchers have discovered that mutation in a gene can led to a form of hereditary colon cancer which was not identified earlier. The researchers discovered genetic changes in the MSH3 gene in patients and identified a new form of colon cancer.
“The knowledge about molecular mechanisms which lead to cancer is also a precondition for the development of new targeted drugs,” said Stefan Aretz from University of Bonn Hospital in Germany.
The formation of large numbers of polyps in the colon has a high probability of developing into colon cancer, if left untreated.
Continue reading “New rare form of hereditary colon cancer identified” »
Jul 28, 2016
Diving into the Fountain of Youth with Aubrey de Grey
Posted by Steve Hill in categories: biotech/medical, ethics, life extension
A new Aubrey de Grey podcast about the work SENS RF is conducting to cure age related diseases.
On today’s episode of Bulletproof Radio Dave and aging expert Aubrey de Grey talk about the 7 aging causes, morbidity & the ethics of immortality. Enjoy!
Jul 28, 2016
Growing Organs on Apples
Posted by Klaus Baldauf in categories: biotech/medical, life extension
Jul 28, 2016
New theory explains how beta waves arise in the brain
Posted by Karen Hurst in categories: biotech/medical, neuroscience
Beta rhythms, or waves of brain activity with an approximately 20 Hz frequency, accompany vital fundamental behaviors such as attention, sensation and motion and are associated with some disorders such as Parkinson’s disease. Scientists have debated how the spontaneous waves emerge, and they have not yet determined whether the waves are just a byproduct of activity, or play a causal role in brain functions. Now in a new paper led by Brown University neuroscientists, they have a specific new mechanistic explanation of beta waves to consider.
The new theory, presented in the Proceedings of the National Academy of Sciences, is the product of several lines of evidence: external brainwave readings from human subjects, sophisticated computational simulations and detailed electrical recordings from two mammalian model organisms.
“A first step to understanding beta’s causal role in behavior or pathology, and how to manipulate it for optimal function, is to understand where it comes from at the cellular and circuit level,” said corresponding author Stephanie Jones, research associate professor of neuroscience at Brown University. “Our study combined several techniques to address this question and proposed a novel mechanism for spontaneous neocortical beta. This discovery suggests several possible mechanisms through which beta may impact function.”
Jul 28, 2016
Yale team designs gene modification system
Posted by Karen Hurst in categories: bioengineering, biotech/medical, genetics
A Yale research team has designed a system to modify multiple genes in the genome simultaneously, while also minimizing unintended effects. The gene-editing “toolbox” provides a user-friendly solution that scientists can apply to research on cancer and other disciplines, according to a news release from Yale.
The study was published on July 26 in Nucleic Acids Research.
The news release states that, with modern genetic engineering techniques, researchers can edit genes in experiments. This allows researchers to study important disease-related genes and may ultimately allow them to treat genetic diseases by making edits in specific sites of the human genome. However, progress has been hampered by several challenges, including the editing of unintended sites — referred to as off-target effects.
Continue reading “Yale team designs gene modification system” »
Jul 28, 2016
U.S. wary on biotech advances; gene editing, CRISPR ‘raising urgency’
Posted by Karen Hurst in categories: bioengineering, biotech/medical, ethics
Hmmm.
We can rebuild him; we have the technology—but Americans question if we should in a new survey designed to assess attitudes to modern biotechnology advances.
A new report, based on a survey of 4,700 U.S. adults coming out of the Pew Research Center, looked at a range of views on certain advances in biology, with opinions split on the ethics and long-term problems associated with enhancing human capacity.
Continue reading “U.S. wary on biotech advances; gene editing, CRISPR ‘raising urgency’” »